Compare KRRO & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRRO | JACK |
|---|---|---|
| Founded | 2014 | 1951 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0M | 178.8M |
| IPO Year | 2019 | 1994 |
| Metric | KRRO | JACK |
|---|---|---|
| Price | $13.47 | $11.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 15 |
| Target Price | ★ $34.80 | $22.40 |
| AVG Volume (30 Days) | 266.1K | ★ 981.3K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $6,392,000.00 | ★ $1,465,314,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 181.46 | N/A |
| 52 Week Low | $5.20 | $8.92 |
| 52 Week High | $55.89 | $27.74 |
| Indicator | KRRO | JACK |
|---|---|---|
| Relative Strength Index (RSI) | 60.38 | 39.14 |
| Support Level | $12.17 | $8.92 |
| Resistance Level | $14.96 | $20.86 |
| Average True Range (ATR) | 0.99 | 0.70 |
| MACD | 0.31 | 0.33 |
| Stochastic Oscillator | 62.16 | 80.17 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America. Its core business includes the Jack in the Box hamburger chain, known for a broad menu that features hamburgers, tacos, sandwiches, salads, and breakfast items. The company also operates the Del Taco brand, which offers a variety of both Mexican and American favorites such as burritos and fries. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.